These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 37587090)
1. The growing implications of obesity for prostate cancer risk and mortality: where do we go from here? Daniels JP; Freedland SJ; Gresham G J Natl Cancer Inst; 2023 Dec; 115(12):1448-1450. PubMed ID: 37587090 [No Abstract] [Full Text] [Related]
2. Obesity and prostate cancer screening, incidence, and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Hurwitz LM; Dogbe N; Barry KH; Koutros S; Berndt SI J Natl Cancer Inst; 2023 Dec; 115(12):1506-1514. PubMed ID: 37382561 [TBL] [Abstract][Full Text] [Related]
4. Reply to Obesity and aggressive prostate cancer and the golden rule: Do not do to others what you do not want done to yourself. Butler SS; Mahal BA Cancer; 2020 May; 126(10):2321-2322. PubMed ID: 32022907 [No Abstract] [Full Text] [Related]
5. Reply to Obesity and aggressive prostate cancer and the golden rule: Do not do to others what you do not want done to yourself. Joshi SS; Filson CP Cancer; 2020 May; 126(10):2322-2323. PubMed ID: 32022901 [No Abstract] [Full Text] [Related]
6. Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial. Kelly SP; Graubard BI; Andreotti G; Younes N; Cleary SD; Cook MB J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 27754927 [TBL] [Abstract][Full Text] [Related]
7. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. Andriole GL; Crawford ED; Grubb RL; Buys SS; Chia D; Church TR; Fouad MN; Isaacs C; Kvale PA; Reding DJ; Weissfeld JL; Yokochi LA; O'Brien B; Ragard LR; Clapp JD; Rathmell JM; Riley TL; Hsing AW; Izmirlian G; Pinsky PF; Kramer BS; Miller AB; Gohagan JK; Prorok PC; J Natl Cancer Inst; 2012 Jan; 104(2):125-32. PubMed ID: 22228146 [TBL] [Abstract][Full Text] [Related]
8. Obesity and prostate cancer detection: insights from three national surveys. Parekh N; Lin Y; Dipaola RS; Marcella S; Lu-Yao G Am J Med; 2010 Sep; 123(9):829-35. PubMed ID: 20800152 [TBL] [Abstract][Full Text] [Related]
9. Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States. Fesinmeyer MD; Gulati R; Zeliadt S; Weiss N; Kristal AR; Etzioni R Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):808-15. PubMed ID: 19258479 [TBL] [Abstract][Full Text] [Related]
10. Obesity and the risk of prostate cancer (United States). Bradbury BD; Wilk JB; Kaye JA Cancer Causes Control; 2005 Aug; 16(6):637-41. PubMed ID: 16049801 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Arm. Halpern JA; Shoag JE; Mittal S; Oromendia C; Ballman KV; Hershman DL; Wright JD; Shih YT; Nguyen PL; Hu JC J Urol; 2017 Feb; 197(2):363-368. PubMed ID: 27569432 [TBL] [Abstract][Full Text] [Related]
12. Obesity and prostate cancer aggressiveness among African and Caucasian Americans in a population-based study. Su LJ; Arab L; Steck SE; Fontham ET; Schroeder JC; Bensen JT; Mohler JL Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):844-53. PubMed ID: 21467239 [TBL] [Abstract][Full Text] [Related]
13. Obesity and prostate cancer. Bandini M; Gandaglia G; Briganti A Curr Opin Urol; 2017 Sep; 27(5):415-421. PubMed ID: 28632505 [TBL] [Abstract][Full Text] [Related]
14. Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Kitahara CM; Berndt SI; de González AB; Coleman HG; Schoen RE; Hayes RB; Huang WY J Clin Oncol; 2013 Jul; 31(19):2450-9. PubMed ID: 23715565 [TBL] [Abstract][Full Text] [Related]
15. Obesity and prostate cancer: making sense out of apparently conflicting data. Freedland SJ; Platz EA Epidemiol Rev; 2007; 29():88-97. PubMed ID: 17478439 [TBL] [Abstract][Full Text] [Related]
16. The uncertain relationship between obesity and prostate cancer: an Italian biopsy cohort analysis. De Nunzio C; Freedland SJ; Miano L; Finazzi Agrò E; Bañez L; Tubaro A Eur J Surg Oncol; 2011 Dec; 37(12):1025-9. PubMed ID: 21963050 [TBL] [Abstract][Full Text] [Related]
18. Colorectal, cervical and prostate cancer screening in Australians with severe mental illness: Retrospective nation-wide cohort study. Tuesley KM; Jordan SJ; Siskind DJ; Kendall BJ; Kisely S Aust N Z J Psychiatry; 2019 Jun; 53(6):550-558. PubMed ID: 30501394 [TBL] [Abstract][Full Text] [Related]
19. Obesity, metabolic syndrome, and prostate cancer. Hsing AW; Sakoda LC; Chua S Am J Clin Nutr; 2007 Sep; 86(3):s843-57. PubMed ID: 18265478 [TBL] [Abstract][Full Text] [Related]
20. Obesity and prostate cancer screening in the USA. Fontaine KR; Heo M; Allison DB Public Health; 2005 Aug; 119(8):694-8. PubMed ID: 15949523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]